Skip to main content
. 2015 May 29;10(5):e0129192. doi: 10.1371/journal.pone.0129192

Table 1. Characteristics of patients at baseline.

Overall Men Women
n 470 296 174
Age (y) 64.2 (11.1) 63.5 (11.2) 65.5 (10.9)
Duration of diabetes (y) 12.2 (8.9) 12.1 (9.5) 12.3 (7.9)
Body mass index (kg/m2) 24.4 (4.3) 24.1 (4.1) 24.8 (4.6)
Systolic blood pressure (mmHg) 130.8 (17.4) 130.5 (16.8) 131.2 (18.4)
Diastolic blood pressure (mmHg) 74.4 (11.2) 75.5 (10.3) 72.9 (11.4)*
Hemoglobin (g/L) 137.9 (13.8) 143.1 (12.3) 129.1 (11.6)*
Anemia (%) 16.0 11.1 24.1*
Hemoglobin A1c (%) 7.2 (1.3) 7.2 (1.4) 7.2 (1.3)
Total cholesterol (mmol/L) 4.8 (0.8) 4.8 (0.8) 4.8 (0.8)
Triglycerides (mmol/L) 1.6 (1.0) 1.6 (1.1) 1.5 (0.9)
Uric acid (μmol/L) 309.3 (83.3) 327.1 (83.3) 279.6 (77.3)*
Creatinine (μmol/L) 67.2 (16.8) 73.4 (15.0) 56.6 (15.0)*
Estimated GFR (ml/min/1.73m2) 76.1 (19.3) 76.2 (19.3) 76.0 (19.2)
Smoking (%) (never/previous/current) 58.5/23.0/18.5 40.2/33.8/26.0 89.7/4.6/5.7*
UACR (mg/g creatinine) at baseline 12.1 (7.5) 12.0 (7.5) 12.4 (7.5)
UACR (mg/g creatinine) after 3 years 21.0 (33.0) 19.7 (32.9) 23.2 (33.2)
Development of albuminuria (%) 17.9 14.9 23.0*
History of cardiovascular disease (%) 16.2 17.6 13.8
Antidiabetic treatment (%)
 Diet only 8.5 8.4 8.6
 Oral hypoglycemic agent 80.0 80.7 78.7
 Insulin 29.5 22.0 35.6*
Hypertension (%) 63.4 61.3 66.7
Antihypertensive drugs (%)
 Calcium channel blockers 26.2 22.3 32.2*
 Rennin-angiotensin system inhibitors 38.5 35.1 44.3*
 Others 17.7 15.5 21.3
Statin (%) 51.1 44.4 62.1*

Data are expressed as mean (SD) or percent of patients. UACR, urinary albumin-creatinine ratio; GFR, glomerular filtration rate;

* P < 0.05 vs men